Portrait of Moskowitz, Jared

Moskowitz, Jared

U.S. Representative FL-23 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
306
Buys / sells
69% / 31%
Last trade
May 6, 2026
Last filing
Jun 19, 2026

Latest disclosed trades

Latest 10 of 306
Ticker Type Traded
GILD Buy May 6, 2026
COR Sell May 6, 2026
AVGO Buy Mar 31, 2026
QCOM Sell Mar 31, 2026
ASML Buy Mar 31, 2026
CB Buy Mar 31, 2026
MCD Buy Mar 31, 2026
GE Buy Mar 31, 2026
AXP Buy Mar 31, 2026
PH Buy Mar 31, 2026

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Moskowitz, Jared stock trade activity

FilingIQ has indexed 306 congressional stock trade disclosures for Moskowitz, Jared. The most recent disclosed transaction is dated May 6, 2026.

Across the full history, 211 purchases and 95 sales have been disclosed under the STOCK Act.

Top tickers traded by Moskowitz, Jared

Frequently asked

How many stock trades has Moskowitz, Jared disclosed?
FilingIQ tracks 306 Periodic Transaction Report disclosures for Moskowitz, Jared, with the most recent dated May 6, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Moskowitz, Jared a net buyer or net seller?
Across the disclosed trade history, 211 (69%) were purchases and 95 (31%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Moskowitz, Jared come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.